Menu
Back to Journals » OncoTargets and Therapy » Volume 9
Original Research
Feasibility, tolerability, and efficacy of the concurrent addition of erlotinib to thoracic radiotherapy in locally advanced unresectable non-small-cell lung cancer: a Phase II trial
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,786 | Dovepress* | 7,090+ | 1,217 | 8,307 | |
| PubMed Central* | 696 | 306 | 1,002 | ||
| Totals | 7,786 | 1,523 | 9,309 | ||
|
*Since 1 March 2016 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 1 | 0 | 1 |
View citations on PubMed Central and Google Scholar